Episodes

  • Improve Refractive Planning and Decision-Making With Clinical Tools

    Improve Refractive Planning and Decision-Making With Clinical Tools
    Dec 23 2025
    In this episode, Gary Wörtz, MD, invites Damien Gatinel, MD, PhD, to share insights into online ophthalmic simulators and tools to help surgeons improve refractive planning. They explore tools for corneal ablation depth predictions, IOL rotation optimization, and more. Dr. Gatinel explains how these simulations can be applied to real-world patient counseling and help ophthalmologists understand what's going on with their patients.
    Show More Show Less
    42 mins
  • Advantages and Outcomes of Epithelium-On Crosslinking

    Advantages and Outcomes of Epithelium-On Crosslinking
    Nov 20 2025
    In this episode, hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite Kenneth Beckman, MD, to discuss the recent FDA approval of Epioxa (Glaukos), an advancement in corneal crosslinking for the treatment of keratoconus that does not require the removal of the corneal epithelium. Dr. Beckman shares insights into the benefits and outcomes of this procedure and details from clinical trials.
    Show More Show Less
    34 mins
  • A Conversation on Lens Selection and AI in Ophthalmology

    A Conversation on Lens Selection and AI in Ophthalmology
    Oct 13 2025
    In this episode, Joaquin De Rojas, MD, and Priya Mathews, MD, MPH, join hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, to discuss how the Tecnis Odyssey IOL differs from previous presbyopia-correcting lenses and how they approach lens selection for their patients. Dr. De Rojas also shares his experience with coding and the use of AI in his practice for digesting significant amounts of data to assist with calculations and treatment algorithms.
    Show More Show Less
    31 mins
  • A New Era of Presbyopia Drop Therapy

    A New Era of Presbyopia Drop Therapy
    Sep 16 2025
    Blake Williamson, MD, MPH, invites Steven Dell, MD, to discuss the recent release of a new presbyopia drop—VIZZ (aceclidine ophthalmic solution, 1.44%; Lenz Therapeutics). Dr. Dell outlines why this drop represents a game-changing option for presbyopia therapy. The once-daily drop lasts for 10 hours and results in a sub-2-mm pupil size to achieve significant gains in near vision. They also review the innovation cycle of this product and how patients have responded to the treatment so far.
    Show More Show Less
    31 mins
  • Ushering in the Future of Cataract and Refractive Surgery

    Ushering in the Future of Cataract and Refractive Surgery
    Aug 25 2025
    Blake Williamson, MD, MPH, and Gary Wörtz, MD, sit down with Robert Weinstock, MD, to reflect on the field of ophthalmology and how to improve things for the next generation of physicians. They discuss pioneers in the field and how they shaped the cataract and refractive subspecialties into what they are today. Dr. Weinstock also shares perspectives into the fellowship match process and gives advice on how prospective fellows can prepare for interviews. The group also explores the benefits and the value of welcoming younger ophthalmologists into a practice.
    Show More Show Less
    28 mins
  • Potential Implications and Benefits of Direct SLT Technology

    Potential Implications and Benefits of Direct SLT Technology
    Jul 22 2025
    Morgan Micheletti, MD, joins hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, to review the evolution of selective laser trabeculoplasty (SLT) and direct SLT (DSLT), highlighting Dr. Micheletti’s experience as an early adopter of DSLT. Dr. Micheletti shares how DSLT can increase efficiency, improve surgeon comfort with the procedure, and help guide patients in the interventional glaucoma treatment pathway. The group also discusses reimbursement and financial considerations for DSLT.
    Show More Show Less
    37 mins
  • Breaking Down the enVista Voluntary Recall

    Breaking Down the enVista Voluntary Recall
    Jun 6 2025
    Cathleen McCabe, MD, and Brent Saunders, chairman and CEO of Bausch + Lomb, join the podcast to break down details of the recent voluntary recall of enVista Aspire, enVista Envy, and certain enVista monofocal IOLs. Hosts Blake Williamson, MD, MPH, and Gary Wörtz, MD, invite discussion on how the Bausch + Lomb team identified an issue, prioritized patient safety, and dove into the data to bring this innovative technology back to patients as quickly and safely as possible.
    Show More Show Less
    31 mins
  • The Highs and Lows of Turning an Idea Into a Business

    The Highs and Lows of Turning an Idea Into a Business
    May 20 2025
    John Berdahl, MD, joins Blake Williamson, MD, MPH, and Gary Wörtz, MD, to share insights into the journey of turning an idea into a product. Dr. Berdahl highlights his experience with the research and development of pressure-equalizing goggles, a nonsurgical, nonpharmacological treatment to lower IOP by creating a small vacuum to relieve pressure on the optic nerve. He describes the positives and negatives of the journey to launch a product, including funding, FDA trials, and beyond.
    Show More Show Less
    40 mins